Testing of these acute-phase sample panels in the r3CPro IgG assay showed 93.94% sensitivity and 88% specificity with AUC = 0.961 (Fig. 2B), indicating that r3CPro is a better antigen to detect both anti-HAV IgM and IgG antibodies during the acute phase of infection. The gene discussed is CD40LG; the disease is infection.